With respect to South Korea, Novartis resolved selected properly-publicized allegations that it experienced made poor payments to HCPs in South Korea by way of spherical tables and third-occasion health care journals. Novartis Korea allegedly transmitted incorrect honoraria to HCPs for spherical tables through healthcare journals to stop compliance